# EYLEA HD

NDC: 61755-050
Generic name: aflibercept
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVITREAL
Marketing started: 20230818

FDA application: BLA761355

## Active ingredients

- AFLIBERCEPT: 8 mg/.07mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86d8848b-111b-4da9-8957-7cccef1b8f66